#United States #digital health #Hoffman Estates #blood pressure #OMRON

OMRON Healthcare Triumphs at the 2025 Digital Health Awards

OMRON Healthcare has made headlines after being recognized as the Best in Class Winner at the prestigious 2025 Digital Health Awards, held by the Digital Health Hub Foundation. The awards celebrate the pinnacle of innovation in healthcare technology, and OMRON secured its spot by showcasing its remarkable blood pressure monitors equipped with AI-powered atrial fibrillation (AFib) detection.

The accolades highlight OMRON's commitment to enhancing the blood pressure monitoring experience. Their devices, such as the OMRON Platinum BP5465 and 10 Series BP7465, are not just ordinary monitors; they come equipped with IntelliSense™ AFib detection technology that automatically screens for AFib during every measurement. This innovation marks a significant leap in early detection practices, allowing individuals to be alerted to potential health risks, including stroke and heart failure, as well as cognitive decline associated with dementia.

Alice Koehler, the Managing Director of OMRON Healthcare North America, expressed the team's excitement regarding this recognition. “We are thrilled to accept this Best in Class Digital Health Award,” she stated. “This year saw a record number of entries in the digital health category, and being acknowledged among such esteemed competition is a testament to our dedication to healthcare innovation.”

Koehler further explained the evolution of blood pressure monitoring and noted the American Heart Association (AHA) and American College of Cardiology (ACC) guidelines that stress the importance of regular home monitoring, especially for those over 40 and expectant mothers. She added, “Atrial fibrillation is often undiagnosed, and with the IntelliSense™ AFib detection, we enable proactive health management.”

The AI technology behind OMRON's monitors employs over 300 mathematical algorithms that analyze the pressure pulse wave generated when the cuff inflates. A recent study published in the Heart Rhythm Journal indicated that OMRON’s blood pressure monitors with IntelliSense™ technology can identify AFib disturbances with impressive accuracy.

The FDA has classified the IntelliSense™ AFib detection as a De Novo device—an approval pathway for groundbreaking innovations that showcases the monitor's potential to transform standard health checks. This further demonstrates OMRON’s longevity in the market, having sold over 400 million devices globally, making them a trusted name among healthcare professionals.

The Digital Health Hub Foundation’s annual awards reveal companies that are pushing the boundaries of healthcare through technology. This year’s event took place at HLTH USA in Las Vegas on October 20, 2025, where winners were celebrated before a gathering of industry leaders, investors, and innovators. Mark H. Goldstein, Chairman of the Digital Health Hub Foundation, spoke about how the winners exemplify innovation that is transformative, practical, scalable, and impactful for today’s healthcare landscape.

In conclusion, as OMRON Healthcare continues to progress the field of home health diagnostics, the company remains dedicated to its mission of empowering individuals to take charge of their health at home. With initiatives like the Best in Class honor at the Digital Health Awards, they reinforce their position as leaders in the digital health industry. For more information about OMRON's groundbreaking products and initiatives, visit OmronHealthcare.com.